St George's, University of London, is a University located in Tooting in South London and is a constituent college of the University of London. St George's has its origins in 1733, and was the second institution in England to provide formal training courses for doctors.

During the past decade, St George's Vaccine Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "St George's Vaccine Institute" #1 collaborator was "European Union" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Novartis Vaccines" with 2 trials as a collaborator, "Foundation for the National Institutes of Health" with 1 trials as a collaborator and "Fundação Ataulpho de Paiva, Rio de Janeiro, Brasil" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "St George's Vaccine Institute" are "HIV Infections" (2 trials), "Acquired Immune Deficiency Syndrome" (1 trials), "Bacterial Infections" (1 trials), "Influenza" (1 trials) and "Responses to Infant Immunisations" (1 trials). Many other conditions were trialed in "St George's Vaccine Institute" in a lesser frequency.

Most popular intervention types in "St George's Vaccine Institute" are "Biological" (6 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ag85B-ESAT6 fusion protein H1" (1 trials), "Baxter Novel Influenza A H1N1 Whole Virus Vaccine" (1 trials), "Boostrix-IPV" (1 trials), "Carbopol 974" (1 trials) and "GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "St George's Vaccine Institute" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St George's Vaccine Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in St George's Vaccine Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St George's Vaccine Institute, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".